Immune Checkpoint Inhibitor-Associated Myositis: Expanding the Spectrum of Cardiac Complications of the Immunotherapy Revolution

被引：156

作者：

Anquetil, Celine ^{[1
,4
]}

Salem, Joe-Elie ^{[3
,5
,6
]}

Lebrun-Vignes, Benedicte ^{[3
]}

Johnson, Douglas B. ^{[7
]}

Mammen, Andrew L. ^{[8
,9
,10
]}

Stenzel, Werner ^{[5
,6
,11
]}

Leonard-Louis, Sarah ^{[2
]}

Benveniste, Olivier ^{[1
,4
]}

Moslehi, Javid J. ^{[5
,6
,7
]}

Allenbach, Yves ^{[1
,4
]}

机构：

[1] Sorbonne Univ, Pitie Salpetriere Univ Hosp, Dept Internal Med & Clin Immunol, 82 Blvd Hop, F-75013 Paris, France

[2] Sorbonne Univ, Pitie Salpetriere Univ Hosp, Dept Neuropathol, Paris, France

[3] Sorbonne Univ, Pitie Salpetriere Univ Hosp, Dept Pharmacol, Reg Ctr Pharmacovigilance, Paris, France

[4] Assoc Inst Myol, INSERM, Ctr Rech Myol, UMRS974, Paris, France

[5] Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Nashville, TN USA

[6] Vanderbilt Univ, Med Ctr, Dept Med, Cardiooncol Program, Nashville, TN USA

[7] Vanderbilt Univ, Med Ctr, Dept Med, Div Oncol, Nashville, TN USA

[8] NIAMSD, Muscle Dis Unit, Lab Muscle Stem Cells & Gene Express, NIH, Bethesda, MD 20892 USA

[9] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA

[10] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA

[11] Charite, Dept Neuropathol, Berlin, Germany

来源：

CIRCULATION | 2018年 / 138卷 / 07期

关键词：

antineoplastic agent; immunological; autoimmune diseases; myasthenia gravis; myocarditis; myositis;

D O I：

10.1161/CIRCULATIONAHA.118.035898

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：743 / 745

页数：3

共 5 条

[1]

Bertrand, Anne ;

Kostine, Marie ;

Barnetche, Thomas ;

Truchetet, Marie-Elise ;

Schaeverbeke, Thierry .

BMC MEDICINE, 2015, 13

[2]

Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study [J].

Dobloug, Gerd Cecilie ;

Svensson, John ;

Lundberg, Ingrid E. ;

Holmqvist, Marie .

ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (01) :40-47

[3]

Myasthenia triggered by immune checkpoint inhibitors: New case and literature review [J].

Gonzalez, Natalia L. ;

Puwanant, Araya ;

Lu, Angela ;

Marks, Stanley M. ;

Zivkovic, Sasa A. .

NEUROMUSCULAR DISORDERS, 2017, 27 (03) :266-268

[4]

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial [J].

Herbst, Roy S. ;

Baas, Paul ;

Kim, Dong-Wan ;

Felip, Enriqueta ;

Perez-Gracia, Jose L. ;

Han, Ji-Youn ;

Molina, Julian ;

Kim, Joo-Hang ;

Arvis, Catherine Dubos ;

Ahn, Myung-Ju ;

Majem, Margarita ;

Fidler, Mary J. ;

de Castro, Gilberto, Jr. ;

Garrido, Marcelo ;

Lubiniecki, Gregory M. ;

Shentu, Yue ;

Im, Ellie ;

Dolled-Filhart, Marisa ;

Garon, Edward B. .

LANCET, 2016, 387 (10027) :1540-1550

[5]

Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis [J].

Moslehi, Javid J. ;

Salem, Joe-Elie ;

Sosman, Jeffrey A. ;

Lebrun-Vignes, Benedicte ;

Johnson, Douglas B. .

LANCET, 2018, 391 (10124) :933-933

← 1 →